Recent News Releases
This section includes a wide variety of news including media releases, photo and video galleries, fact sheets and publications.
- Initial apixaban dosing in patients with atrial fibrillation
- Efficacy and safety of switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide (E/C/F/TAF) in virologically suppressed women
- Burden of exposure to potential interactions between antiretroviral and non-antiretroviral medications in a population of HIV-positive patients aged 50 years or older
- Alirocumab vs usual lipid-lowering care as add?on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM-DYSLIPIDEMIA randomized trial
- Effect of cumulative exposure to corticosteroid and DMARD on radiographic progression in rheumatoid arthritis: Results from the ESPOIR cohort
PHARMACOLOGY
- An early view of real-world patient response to sacubitril/valsartan: A retrospective study of patients with heart failure with reduced ejection fraction
- Efficacy and safety of alirocumab in individuals with diabetes mellitus: Pooled analyses from five placebo-controlled phase 3 studies
- Dabigatran, rivaroxaban and apixaban vs high TTR warfarin in atrial fibrillation
- Aldosterone antagonist therapy and mortality in patients with ST-segment elevation myocardial infarction without heart failure: A systematic review and meta-analysis
- Impact of antithrombotic regimen on mortality, ischemic, and bleeding outcomes after transcatheter aortic valve replacement
CLINICAL PHARMACOLOGY
- Histogram analysis of apparent diffusion coefficient from whole-body diffusion-weighted MRI to predict early response to chemotherapy in patients with metastatic colorectal cancer: Preliminary results
- Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance
- The diagnostic role of BAP1 in serous effusions
- Which type of breast cancers is undetectable on ring-type dedicated breast PET?
- Management outcomes of diverticulitis and colitis in patients with active cancer
ONCOLOGY
